search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ANTI-POLLUTION


is common for individuals to be exposed to all three of these threats at the same time, every time they go outside and if they do not effectively cover their heads, the scalp can be exposed even if the individuals have thick hair. Topical application of the formulations


containing between 1 and 3% of the antioxidant complex can help to minimise the formation of cellular ROS in the DP cells, based on the in vitro results demonstrated in these studies. This may be particularly important as it is not common for individuals to cover or treat their scalps with sunscreens, which could potentially help reduce the impacts from UVB radiation. However, even sunscreens may have limited impact from the effects of urban particulate pollution or HEV light that are also common exogenous threats in both urban and rural locales.


References 1. Lemasters JJ, Ramshesh VK, Lovelace GL, Lim J, Wright GD, Harland D, Dawson TL. Compartmentation of mitochondrial and oxidative metabolism in growing hair follicles: A ring of fire. J. Invest. Dermatol. 2017: 137:1434-1444


Siltech 2ChAd 20.qxp_Layout 1 09/09/2021 11:35 Page 1


2. Calvo-Sanchez MI, Fernandez-Martos S, Espada J. A photodynamic tool to promote a sustained ROS-dependent growth of human hair follicle in ex vivo culture. Method. Mol. Biol. 2021: 2202:51-61


3. Calvo-SanchezMI, Fernandez-Martos S, Montoya MI, Espada J. Intrinsic activation of cell growth and differentiation in ex vivo cultured human hair follicles by a transient


30 minute exposure (13.5J/cm2)■ 60 minute exposure (27J/cm2 PC


45.00 40.00 35.00 30.00 25.00 20.00 15.00 10.00 5.00 0.00


)■


67


* * * * * Non-Exposed Untreated


0.015% Trolox 0.005% BHT 0.001% BHT 3% SC-Help Defense


Treatment


Figure 4: ROS formation due to exposure of DP cells to 13.5 mJ/cm2 27 mJ/cm2


of blue light for 60 minutes Note: Measured in RFUs. Asterisks indicate statistical significance against untreated DP cells


endogenous production of ROS. Sci. Rep. 2019: 9: 4509. doi: 10.1038/s41598-019- 39992-8.


4. Grabenhofer R. Beiersdorf refutes reports that artificial blue light causes skin damage. Cosmet. Toilet. Online. 2021


5. Duteil L, Queille-Roussel C, Lacour JP, Montaudie H, Passeron T. Short-term


exposure to blue light emitted by electronic devices does not worsen melasma. J. Am. Acad. Dermatol. 2020: 83:913-914.


6. Jia W, Diwakar G, Kata N, Kern D, Milner T. Quantification of blue light irradiation dose emitted by electronic devices and its potential impact on human skin. J. Invest. Dermatol. 2021: 141:S90.6.


of blue light for 30 minutes &


1% SC-Help Defense


* * * *


www.personalcaremagazine.com


November 2021 PERSONAL CARE


ROS Formulation (RFU)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104